TABLE VII.A.5.
Study | Year | LOE | Study design | Study groups | Clinical endpoints | Conclusion |
---|---|---|---|---|---|---|
Gami et al.716 | 2004 | 3b | Case–control study | 1) 151 consecutive patients undergoing electrocardioversion for AF 2) 312 consecutive patients without AF referred to a general cardiology practice |
Presence of OSA identified based on a Berlin Questionnaire score of 2–3 | Adjusted OR of 2.19 (95% CI 1.40–3.42) for the association of AF and OSA |
Porthan et al.717 | 2004 | 4 | Case–control study | 1) 59 patients with AF identified from hospital records, free of known causes of AF 2) 56 age- and sex-matched controls from general population registry, free of AF or known causes of AF |
Presence of “sleep apnea syndrome” based on AHI from in-lab cardiorespiratory polygraphy and sleep apnea symptoms | No significant difference between groups in prevalence of sleep apnea syndrome (32% in AF versus 29% in control) |
Mehra et al.719 | 2006 | 3b | Nested case–control study within a community-based cohort study | Participants in the Sleep Heart Health Study 1) 228 subjects with AHI ≥30 on home polysomnography 2) 338 subjects with AHI <5, frequency-matched on age, sex, race/ethnicity, BMI |
Presence of arrhythmias on bipolar lead I ECG recorded on home polysomnography | Atrial fibrillation was present in 4.8% of severe OSA group and 0.9% of controls, with adjusted OR 4.02 (95% CI 1.03–15.74) for the association of AF and severe OSA |
Stevenson et al.715 | 2008 | 3b | Case–control study | 1) 90 patients with paroxysmal or persistent AF 2) 45 patients referred to the same tertiary care center without AF, frequency match for age, and sex |
AHI >15 on home polysomnography | Mean AHI was higher in the AF group than the control group (23.2 [SD 19.3 vs. 14.7 [SD 12.4]), with adjusted OR 3.04 (95% CI1.24–7.46) for the association of AF and OSA |
Braga et al.707 | 2009 | 3b | Case–control study | 1) 57 consecutive patients with chronic persistent AF in Sao Paulo, Brazil 2) 32 age-, sex-, and BMI-similar subjects from the Sao Paolo general population participating in the Epidemiologic Sleep Study (EPISONO) |
From in-lab polysomnography: 1) AHI 2) Sleep time with SaO2 <90% |
No significant difference between groups in mean AHI (24.3 [SD 16.5] vs. 19.1 [SD 15.3]), but higher prevalence of AHI ≥10 (81.6% vs. 60%, p = 0.03) and longer time with SaO2 <90% in the AF group |
Bitter et al.706 | 2009 | 4 | Case series | 150 patients with persistent AF and normal left ventricular ejection fraction | AHI from cardiorespiratory polygraphy, classified as central or obstructive based on the predominant event type | OSA was present in 42.7% (18% mild, 12% moderate, 12.7% severe); an additional 31.3% had central sleep apnea |
Mehra et al.720 | 2009 | 3b | Community-based cross-sectional cohort study | 2911 participants in the Outcomes of Sleep Disorders in Older Men Study | Association of nocturnal arrhythmias present on home polysomnography with total AHI, obstructive AHI (obstructive apneas plus all hypopneas), and central apnea index | There was a progressive increase in prevalence of AF with increasing quartile of total AHI, from 3.2% to 7.3%. The adjusted OR in the highest AHI quartile was 2.15 (95% CI 1.19–3.89). This effect was stronger for the central apnea index, and was non-significant for the obstructive AHI in adjusted analyses |
Pathak et al.330 | 2014 | 4 | Case series | 149 patients referred for pulmonary vein isolation procedure for AF | Presence of severe OSA (AHI ≥30) on in-lab polysomnography | 86 of 149 patients (57.7%) had severe OSA |
Kwon et al.718 | 2015 | 3b | Community-based cross-sectional cohort study | 2048 participants in the Multi-Ethnic Study of Atherosclerosis Sleep Study | Association of AHI from in-home polysomnography at MESA exam 5 with AF based on International Classification of Disease codes or ECG recordings over the preceding approximately 10 years (n = 92) or present on the polysomnogram ECG (an additional n = 8) | There was an increase in AF prevalence from 4.0% in those with none to mild OSA, 6.0% in those with moderate OSA, and 7.5% in those with severe OSA. The adjusted OR was 1.22 (95% CI 0.99–1.49) for each 1 SD increase in AHI. |
Abuammar et al.704 | 2018 | 4 | Case series | 100 consecutive patients with AF without prior diagnosis of OSA recruited from arrhythmia clinics | Presence and severity of OSA from mean of 2 nights of home polysomnography | OSA was present in 85% of subjects (38% mild, 23% moderate, and 24% severe) |
Traaen et al.710 | 2019 | 4 | Case series | 579 patients with paroxysmal AF admitted for pulmonary vein isolation procedure, without known OSA | Presence and severity of sleep apnea from mean of 2 nights of cardiorespiratory polygraphy | Sleep apnea was present in 83% of subjects (41% mild, 30% moderate, and 12% severe); this was OSA in 97.5% of those with sleep apnea, central sleep apnea in 2.5% |
Gami et al.414 | 2007 | 2b | Retrospective cohort study | 3542 adults without history of AF referred for diagnostic polysomnography 1) OSA defined as AHI ≥5 (n = 2626), with group mean AHI 36 (SD 32) 2) No OSA | Incidence of AF based on electronic medical record review, with mean follow-up of 4.7 years | AF occurred in 2.1% of those without OSA, 4.3% of those with OSA, with unadjusted HR 2.18 (95% CI 1.34–3.54). This effect was restricted to those under age 65. In multivariate analysis, the difference between awake and asleep oxygen saturation was a strong predictor of incident AF. It is not clear in this study whether measures of OSA per se are independently associated with incident AF |
Cadby et al.724 | 2015 | 2b | Retrospective cohort study | 6841 adults without history of AF referred for diagnostic polysomnography 1) OSA defined as AHI 0≥5 (n = 4352) 2) No OSA |
Incidence of hospitalization for AF based on review of Western Australia Hospital Morbidity and Mortality Data, with median follow-up of 11.9 years | AF occurred in 8.6% of those with OSA and 3.3% of those without OSA, with adjusted HR 1.55 (95% CI 1.21–2.00) for the association of OSA with incident AF. There was a modest dose–response relationship, with adjusted HR increasing from 1.48 in those with mild OSA to 1.73 in those with severe OSA. Both AHI and time at SaO2 <90% were associated with incident AF |
May et al.725 | 2016 | 2b | Community-based cohort study | Of 2316 participants in the Outcomes of Sleep Disorders in Older Men Study who were free of AF at baseline, 852 had a follow-up sleep study after approximately 6 years and 843 of these had outcome data and were analyzed | Association of AHI from baseline in-home polysomnography with incident adjudicated or self-reported AF (the proportion of adjudicated versus self-report AF is not stated) | AF occurred in 10.0% of those with AHI <15 and 14.2% of those with AHI ≥15 (adjusted OR 1.15 [95% CI 0.72–1.84]). There was no association of AF with obstructive AHI; however, a central apnea index ≥5 was present in 48 participants at baseline and the incidence of AF in this group was 22.9% (adjusted OR 2.34 [95% CI 1.14–4.77]) |
Tung et al.726 | 2017 | 2b | Community-based cohort study | Of 6441 participants in the Sleep Heart Health Study, 3346 had repeat polysomnography after approximately 5 years. Of these 388 were excluded due to restrictions on data use and 46 due to prevalent AF at baseline, yielding an analytic sample of 2912 participants. | Association of OSA and central sleep apnea with incident AF based on parent cohort adjudication or 12-lead ECG at the time of the second polysomnogram; median follow-up was 5.3 years; OSA was classified based on the obstructive AHI (OAHI, obstructive apneas plus all hypopneas per hour of sleep) | AF incidence increased with OSA severity from 9.6% of those with OAHI <5% to 16.4% with AHI ≥30; however, adjusting for age, sex, race and BMI there was no positive association of OSA with AF. Central apnea index ≥5 was present in 74 participants at baseline, and the incidence of AF in this group was 25.7% (adjusted OR 1.71, 95% CI 0.89–3.30, increasing to 3.00, 95% CI 1.40–6.44, with further adjustment for hypertension, diabetes, and cardiovascular disease) |
Kendzerska et al.723 | 2018 | 2b | Retrospective cohort study | 8256 patients without prior history of arrhythmia referred for diagnostic polysomnography 1) 2263 with AHI < 5 2) 2260 with 5 ≤ AHI < 15 3) 1823 with 15 ≤ AHI ≤ 30 4) 2263 with AHI > 30 |
Time to first hospitalization with a diagnosis of AF or atrial flutter, using Ontario Provincial Health Administrative Administrative Data, with median follow-up of 10 years | In unadjusted analyses, incident hospitalized AF increased with increasing severity of OSA based on either AHI or percent time at SaO2 < 90%; however, in multivariate models that included BMI these associations were not significant, with hazard ratios < 1.0 for each OSA severity compared to AHI <5. Only when comparing those with more than 30% of sleep time at SaO2 < 90% (n = 463) to those with less severe hypoxemia, was the adjusted HR significant (1.77, 95% CI 1.15–2.74). |
Mazza et al.714 | 2009 | 1b | Clinic-based cohort study | 158 consecutive patients admitted for electrocardioversion for AF; all had polysomnography the night prior to cardioversion 1) AHI ≥15 (n = 49) 2) AHI <15 (n = 109) |
Recurrence of AF over 1-year follow-up | AF recurred in 69% of patients with AHI ≥15 and in 43% of those with AHI <15 (adjusted OR 3.04, 95% CI 1.45–6.36) |
Matiello et al.727 | 2010 | 1b | Clinic-based cohort study | 174 consecutive patients undergoing pulmonary vein isolation procedure for AF; all screened with Berlin Questionnaire, and the 51 with score of 2–3 underwent home cardiorespiratory polygraphy 1) Low risk Berlin Questionnaire or AHI <10 on polygraphy (n = 132) 2) AHI 10–<30 (n = 17) 3) AHI ≥30 (n = 25) |
Recurrence of AF over mean follow-up of 17 (SD 11.5) months | Estimated 1-year recurrence free survival was 48.5% in the low-risk group, 30.4% in those with AHI 10–<30, and 14.3% in those with AHI ≥30. Adjusted OR for recurrence was 1.57 (95% CI 0.83–3.00) for AHI 10–<30 and 1.87 (95% CI 1.11–3.16) for AHI ≥30 |
Bitter et al.711 |
2012 | 1b | Clinic-based cohort study | 82 consecutive patients undergoing pulmonary vein isolation procedure for AF, 75 evaluable; all underwent in-hospital cardiorespiratory polygraphy 1) AHI <15 (n = 53) 2) AHI ≥15 (n = 22, of which 15 were predominantly obstructive and seven were predominantly central) |
Recurrence of AF over a median follow-up of 12 months | AF recurred in 45.5% of those with AHI ≥15 and 24.5% of those with AHI <15. The adjusted HR for AF recurrence in those with AHI ≥15 was 3.20 (95% CI 1.14–8.95) compared to those with AHI <15. Not analyzed separately by obstructive versus central pattern |
Szymanski et al.709 | 2015 | 1b | Clinic-based cohort study | 290 consecutive patients admitted for pulmonary vein isolation procedure for AF; in-hospital cardiorespiratory polygraphy the night prior to the procedure; polygraphy was inadequate in 22 patients and ablation was not performed in 14; 3 patients with central sleep apnea excluded 1) AHI <5 (n = 136) 2) AHI ≥5 (n = 115) |
Recurrence of AF over a mean follow-up of 30 months | AF recurred in 65.2% of those with AHI ≥5 and 45.6% of those with AHI <5. AF recurrence increased progressively with more severe OSA, to 81.8% in those with AHI ≥30. The adjusted OR for AF recurrence in those with AHI ≥5 was 2.58 (95% CI 1.91–4.10) |
Kawakami et al.713 | 2016 | 1b | Clinic-based cohort study | 133 consecutive patients admitted for pulmonary vein isolation procedure for AF; in-hospital cardiorespiratory polygraphy the night prior to the procedure 1) AHI <15 (n = 69) 2) AHI 15–<30 (n = 39) 3) AHI ≥30 (n = 16) |
Recurrence of AF over a mean follow-up of 13 (SD 7) months | AF recurred in 25% of those with AHI <15, 49% of those with AHI 15–<30, and 69% of those with AHI ≥30. However, in multivariate analysis, the association of AHI with recurrent AF was significant only in the subgroup with paroxysmal AF (adjusted HR 1.04, 95% CI 1.002–1.065) |